Benefit of Tocilizumab Therapy for Adult-Onset Still Disease Complicated With Acute Respiratory Distress Syndrome

J Clin Rheumatol. 2016 Aug;22(5):291-3. doi: 10.1097/RHU.0000000000000374.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Administration, Intravenous
  • Adult
  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Humans
  • Immunologic Factors / administration & dosage
  • Lung / diagnostic imaging
  • Lung Diseases, Interstitial* / diagnosis
  • Lung Diseases, Interstitial* / etiology
  • Lung Diseases, Interstitial* / physiopathology
  • Male
  • Radiography, Thoracic / methods
  • Receptors, Interleukin-6 / antagonists & inhibitors
  • Respiratory Distress Syndrome* / etiology
  • Respiratory Distress Syndrome* / physiopathology
  • Still's Disease, Adult-Onset* / complications
  • Still's Disease, Adult-Onset* / therapy
  • Tomography, X-Ray Computed / methods
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • Immunologic Factors
  • Receptors, Interleukin-6
  • tocilizumab